Extensior 1mg Injection Combipack

Extensior 1 mg Injection Combipack – Semaglutide for Type 2 Diabetes Management

Extensior 1 mg Injection Combipack is a prescription injectable medicine containing Semaglutide 1 mg per dose. It is used alongside an appropriate diet and regular physical activity to improve blood-sugar control in adults with insufficiently controlled type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood glucose is elevated, reduces inappropriate glucagon secretion, and slows stomach emptying. Each pre-filled pen contains 4 mg of semaglutide in 3 mL and delivers 4 fixed 1 mg doses. The combipack contains one pre-filled pen and four disposable needles. The 1 mg strength is generally used after treatment with a lower semaglutide dose. It should not be used as the initial starting dose unless specifically directed by the prescribing healthcare professional.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 1 mg Per Dose: Each injection delivers a fixed 1 mg dose of semaglutide.
• Four-Dose Pen: Each 3 mL pre-filled pen delivers four weekly doses.
• Supports Blood-Sugar Control: Helps reduce elevated blood-glucose levels in adults with type 2 diabetes.
• Once-Weekly Administration: Designed for use on the same day each week.
• Pre-Filled Pen: Allows accurate subcutaneous administration of the prescribed fixed dose.
• Prescription Medicine: Must be used according to a healthcare professional’s treatment plan.

Active Ingredient

• Semaglutide 1 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces excess glucagon secretion, and slows gastric emptying.

Uses

• Improvement of blood-sugar control in adults with type 2 diabetes mellitus.
• Used together with an appropriate diet and regular physical activity.
• May be used alone when metformin is unsuitable due to intolerance or another medical reason.
• May be prescribed with other oral or injectable diabetes medicines when additional glucose control is required.
• Supports reduction of HbA1c as part of a medically supervised diabetes-management programme.

How to Use

• Use Extensior 1 mg Injection exactly as prescribed by your healthcare professional.
• Inject one prescribed dose once weekly, preferably on the same day each week.
• It may be administered at any time of the day, with or without meals.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with every weekly dose.
• Attach a new compatible disposable needle before every injection.
• Turn the dose selector until the dose counter shows exactly 1 mg.
• Do not count pen clicks or attempt to select a partial dose.
• Press and hold the dose button until the dose counter returns to zero.
• Keep the needle under the skin and count slowly to six before removing it.
• Remove and safely discard the needle immediately after every injection.

Precautions

• Extensior 1 mg is not normally a starting dose and is generally reached after treatment with lower semaglutide strengths.
• It is not intended for type 1 diabetes or diabetic ketoacidosis and is not a substitute for insulin.
• Seek urgent medical attention for severe and persistent abdominal pain, particularly if accompanied by vomiting.
• Nausea, vomiting, and diarrhoea may cause dehydration and may affect kidney function.
• The risk of low blood sugar may increase when semaglutide is used with insulin or a sulfonylurea medicine.
• Report sudden or significant changes in vision promptly.
• Do not combine it with another semaglutide product or another GLP-1 receptor agonist unless specifically prescribed.
• Seek immediate medical assistance for facial swelling, breathing difficulty, severe rash, fainting, or another serious allergic reaction.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or acid reflux.
• Abdominal bloating or increased gas.
• Reduced appetite.
• Headache or dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with insulin or certain other diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Before first use, store the pen in a refrigerator between 2°C and 8°C.
• Keep it away from the refrigerator’s cooling element.
• Do not freeze or use a pen that has been frozen.
• Keep the pen cap attached to protect the medicine from light.
• After first use, the pen may be stored below 30°C or refrigerated between 2°C and 8°C for up to six weeks.
• Do not store the pen with a needle attached.
• Do not expose the pen to excessive heat or direct sunlight.
• Do not use the solution if it is cloudy, coloured, or contains visible particles.
• Discard the pen after the four prescribed doses have been used.
• Keep out of the sight and reach of children.

Legal Disclaimer: Extensior 1 mg Injection Combipack is a prescription semaglutide medicine intended for adults with type 2 diabetes mellitus. The 1 mg strength is generally used after gradual dose escalation. The dose, concurrent diabetes medicines, treatment duration, and continued use must be determined by a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official patient leaflet and pen instructions.